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RelB Is Differentially Regulated by IkB Kinase-a in
B Cells and Mouse Lung by Cigarette Smoke
Se-Ran Yang1, Hongwei Yao1, Saravanan Rajendrasozhan1, Sangwoon Chung1, Indika Edirisinghe1,
Samantha Valvo1, George Fromm2, Michael J. McCabe Jr.1, Patricia J. Sime1, Richard P. Phipps1,2,3,
Jian-Dong Li3, Michael Bulger4, and Irfan Rahman1
1Department of Environmental Medicine, Lung Biology and Disease Program, and 2Departments of Pediatrics, 3Microbiology and Immunology,
and 4Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York
Theactivationof transcriptionfactorNF-kB is controlledby twomain
pathways: the classical canonical (RelA/p65-p50)- and the alterna-
tive noncanonical (RelB/p52)–NF-kB pathways. RelB has been
shown to play a protective role in RelA/p65-mediated proinflamma-
tory cytokine release in immune–inflammatory lymphoid cells.
Increased infiltration of macrophages and lymphoid cells occurs in
lungs of patients with chronic obstructive pulmonary disease,
leading to abnormal inflammation. We hypothesized that RelB,
and its signaling pathway, is differentially regulated in macrophages
and B cells and in lung cells, leading to differential regulation of
proinflammatory cytokines in response to cigarette smoke (CS). CS
exposure increased the levels of RelB and NF-kB–inducing kinase
associated with recruitment of RelB on promoters of the IL-6 and
macrophage inflammatory protein-2 genes in mouse lung. Treat-
ment of macrophage cell line, MonoMac6, with CS extract showed
activation of RelB. In contrast, RelB was degraded by a proteasome-
dependent mechanism in B lymphocytes (human Ramos, mouse
WEHI-231, and primary mousespleen B cells), suggesting that RelB is
differentially regulated in lung inflammatory and lymphoid cells in
response to CS exposure. Transient transfection of dominant nega-
tive IkB-kinase-a and double mutants of NF-kB–inducing kinase
partially attenuated the CS extract–mediated loss of RelB in B cells
and normalized the increased RelB level in macrophages. Taken
together, these data suggest that RelB is differentially regulated in
response to CS exposure in macrophages, B cells, and in lung cells by
IkB-kinase-a–dependent mechanism. Rapid degradation of RelB
signals for RelA/p65 activation and loss of its protective ability to
suppress the proinflammatory cytokine release in lymphoid B cells.
Keywords: chronic obstructive pulmonary disease; cigarette smoke;
NF-kB; RelB; B cells
Cigarette smoke (CS) is a major etiologic factor in the patho-
genesis of chronic obstructive pulmonary disease (COPD), which
is characterized by a chronic inflammatory response in the lungs
with a progressive and irreversible airflow limitation (1). We and
others have shown that CS exposure resulted in lung inflamma-
tion with an increase in inflammatory cell influx that includes
macrophages, neutrophils, CD81 lymphocytes, and increased
release of proinflammatory mediators (2–10). The numbers of
neutrophils, macrophages, and lymphocytes have been shown to
be increased in both airways and parenchyma of patients with
COPD (11). Recently, it has been reported that the progression
and severity of COPD is associated with increasing infiltration of
airways by innate and adaptive inflammatory immune cells, such
as polymorphonuclear leukocytes, macrophages, lymphocyte
subtypes CD41 and CD81 T cells, and B lymphocytes, which
are accumulated in absolute volume in the pool of inflammatory
cells and form lymphoid follicles (12, 13). These lymphoid cells,
such as CD41 and CD81 T cells and B cells, are involved in
adaptive immune responses that are highly specific and exhibit
a specific ‘‘memory’’ to previous insults. Furthermore, these cells
are involved in airway obstruction of the small airways and are
associated with a thickening of the airway wall in patients with
COPD (12). Recently, Van der Strate and coworkers (13) have
reported that B-cell follicles are detectable in lung sections of
mice with airspace enlargement and in patients with emphysema,
associated with increased release of proinflammatory mediators
(IL-4, IL-6, keratinocyte chemoattractant [KC, IL-8], regulated
on activation, normal T-cell expressed and secreted [RANTES],
monocyte chemoattractant protein [MCP]-1, interferon-inducible
protein [IP]-10, and IL-13), suggesting that proliferating B cells
contribute to the inflammatory process in the aggregates of lym-
phoid follicles and/or development and perpetuation of em-
physema. However, the presence of these B-cell follicles in
CS-mediated, NF-kB–driven inflammatory process, specific antigen-
driven reactions, or autoantibody production in the pathogen-
esis of COPD is not known.
The NF-kB family of transcription factors is essential for the
control of immune and inflammatory responses as well as cell
survival, proliferation and differentiation. The classical pathway
requires IkB-kinase (IKK)-b activity, whereas the alternative
pathway involves selective nuclear translocation of p52:RelB
dimer upon NF-kB–inducing kinase (NIK)-mediated phosphor-
ylation of IKK-a. We have recently shown that RelA/p65 subunit
of NF-kB is activated in response to CS and oxidants, leading to
increased release of inflammatory mediators that are involved in
airway inflammation and pathogenesis of COPD (4, 14–19). The
alternative NF-kB pathway activated by CD40 ligand, B-cell
activating factor, IL-1b, and lymphotoxin-b is important in
lymphoid organogenesis, B-lymphocyte differentiation, immune
response, and antibody production (20–23). Furthermore, it has
also been shown that RelB inhibits NF-kB–dependent proin-
flammatory mediator gene expression, and RelB is inducibly
degraded upon activation of lymphoid cells (24, 25), whereas
CLINICAL RELEVANCE
RelB is rapidly degraded in B cells, but not in macrophages
and mouse lungs, in response to cigarette smoke exposure.
RelB may be a potential target in controlling inflammation
in lymphoid immune cells of patients with chronic obstruc-
tive pulmonary disease.
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activation of RelB leads to proinflammatory cytokine release in
nonlymphoid cells (21). Moreover, IKK-a plays a critical role in
activation of the RelB/p52 pathway by processing p100 to form
p52, which then associates predominantly with RelB in the
cytoplasm (23, 26–28). The roles of RelB and its signaling
pathway in response to environmental agents, particularly in
response to CS in different immune–inflammatory and lymphoid
cell types, are not known. We hypothesized that CS activates the
alternative RelB/p52 pathway, leading to proinflammatory cyto-
kine release in mouse lung, B-lymphocytes, and in human
monocyte/macrophage (MonoMac6). Since IKK-a and NIK play
critical roles in alternative NF-kB pathway, we studied the role of
IKK-a and NIK in CS-mediated RelB activation in both
lymphoid and nonlymphoid cells.
MATERIALS AND METHODS
Reagents
Unless otherwise stated, all biochemical reagents used in this study
were purchased from Sigma Aldrich, Inc. (St. Louis, MO). Antibodies
used include the following: b-actin (CP-01; Oncogene, San Diego, CA),
NIK (A-12), RelB (C-19), NF-kBp52 (K-27), RelA/p65, and CD19
(SC-8417, SC-226, SC-298X, SC-372, and SC-8498; Santa Cruz Bio-
technology Inc., Santa Cruz, CA), and IKK-a (05-536; Upstate,
Charlottesville, VA).
Animals
Adult male C57BL/6J mice (8–10 wk old, 37 6 1.5 g; Jackson
Laboratory, Bar Harbor, ME) were housed in the Inhalation Core
Facility of the University of Rochester. The Animal Research Com-
mittee of the University of Rochester approved all animal experimen-
tal procedures described here.
CS Exposure
Mice (6–8/group) were used for acute (3 d) CS exposure. The mice
were placed in individual compartments of a wire cage, which was
placed inside an aerated plastic box connected to the smoke source.
The CS was generated from 2R4F research cigarettes (total particulate
matter [TPM] concentration, 11.7 mg/cigarette; tar, 9.7 mg/cigarette;
nicotine, 0.85 mg/cigarette; University of Kentucky, Lexington, KY).
CS exposure was performed according to the Federal Trade Commis-
sion protocol (1 puff/min of 2-s duration and 35 ml volume) in an
automatic Baumgartner-Jaeger CSM2082i CS machine (CH Technol-
ogies, Westwood, NJ). Mainstream CS was diluted with filtered air and
directed into the exposure chamber. The smoke exposure (TPM per
cubic meter of air, mg/m3) was monitored in real time with a MicroDust
Pro-aerosol monitor (Casella CEL, Bedford, UK) and verified daily by
gravimetric sampling. The smoke concentration was set at a nominal
value ofz 300 mg/m3 TPM by adjusting the flow rate of the dilution air
(4, 29–33). Sham control animals were exposed only to filtered air in
the same manner for the same duration. Mice received two 1-hour
exposures (1 h apart) per day for 3 days, and were killed 24 hours after
the last exposure. The concentration of carbon monoxide in the CS-
filled chamber was approximately 350 ppm. The dosimetry of carbon
monoxide in CS was estimated by measuring blood carboxyhemoglobin
levels. Mice tolerated CS without evidence of toxicity (carboxyhemo-
globin levels z 17%, and no body weight loss).
Tissue Harvest and Bronchoalveolar Lavage
Mice were injected with 100 mg/kg body weight of pentobarbiturate
(Abbott laboratories, Abbott Park, IL) intraperitoneally, and then
killed by exsanguination. The heart and lungs were removed en bloc,
and the lungs were lavaged three times with 0.5 ml of 0.9% sodium
chloride. The lavage fluid was centrifuged, and the cell-free super-
natants were frozen at 2808C for luminex-based multiplex assay.
Analysis of Proinflammatory Mediators in Bronchoalveolar
Lavage Fluid
Mouse bronchoalveolar lavage (BAL) fluid (150 ml) was analyzed for
the cytokine levels using the sensitive mice Multi-Analyte Profile
(version 1.6) screening by Luminex (Rules-Based Medicine, comarketed
with Charles River Laboratories, Austin, TX). The assays permit
simultaneous cytometric quantification of multiple chemokines/cyto-
kines with minimal sample volume.
Immunohistochemistry
The expression and levels of RelB, RelA/p65, and CD191 B cells (34)
were measured in fixed mouse lung sections (4 mm thick) by immuno-
histochemical staining using specific antibodies (1:100 dilution), with
the avidin–biotin–peroxidase complex method followed by hematoxy-
lin counter staining. Preimmune serum was used as negative control.
Appearance of dark brown color represents the presence of RelB,
RelA/p65, and B cells in the lung sections.
B-Cell Isolation from Mouse Spleen
B lymphocytes were isolated from mouse spleen using a B-cell isolation
kit (MACS, mouse B-cell isolation kit no. 130–090–862; Miltenyi
Biotec, Auburn, CA), according to the manufacturer’s instructions.
The spleens were removed from 6- to 8-week-old C57BL/6J mice, and
splenic cells were dispersed by grinding between glass slides with
MACS running buffer (0.5% FBS and 2 mM EDTA in PBS) to obtain
a single-cell suspension. Cells were resuspended with MACS running
buffer (40 ml) with a B-cell biotin antibody cocktail (10 ml; Miltenyi
Biotech) per 1 3 107 cells, followed by removing erythrocyte lysis
buffer (Sigma). After 15-minute incubation on ice, MACS antibiotin
beads (20 ml/13 107 cells; Miltenyi Biotech) and MACS running buffer
(30 ml/1 3 107 cells) were added to the cell suspension for magnetic
labeling. Cell pellets were washed and then resuspended with MACS
running buffer for sorting using an AutoMACS Separator (Miltenyi
Biotech). Flow cytometry was used to determine the purity of enriched
B cells (B220 versus CD3), which was . 98%.
Cell Culture
The MonoMac6 cell line, which was established from peripheral blood
of a patient with monoblastic leukemia (35, 36), were grown in RPMI
1640 medium supplemented with 10% FBS, 2 mML-glutamine, 100 mg/ml
penicillin, 100 U/ml streptomycin, 0.1 mM nonessential amino acids,
1 mM sodium pyruvate, 1 mg/ml human holotransferrin, and 1 mM
oxaloacetic acid. These cells do not require phorbol myristate acetate
to differentiate into the macrophages, thus avoiding any stress to the
cells. Human Burkitt B lymphoma cells (Ramos B cells), the line of
which was established from the ascitic fluid of a 3-year-old boy with
American-type Burkitt lymphoma (37), were grown in RPMI 1640
medium supplemented with 5 to 10% FBS, 0.1 mM nonessential amino
acids, 1 mM sodium pyruvate, 2 mM L-glutamine, 10 mM HEPES,
100 mg/ml penicillin, 100 U/ml streptomycin and 50 mM 2-mercapthoe-
thanol. Mouse immature B cells (WEHI-231) were grown in RPMI
1640 medium supplemented with 10% FBS, 100 mg/ml penicillin, 100 U/ml
streptomycin, and 50 mM 2-mercapthoethanol (38). The cells were
cultured at 378C in a humidified atmosphere containing 7.5% CO2.
Preparation of Aqueous CS Extract
Research-grade cigarettes (1R3F) were obtained from the Kentucky
Tobacco Research and Development Center at the University of
Kentucky (Lexington, KY). Tar and nicotine contents of 1R3F were
15 mg/cigarette and 1.16 mg/cigarette, respectively. CS extract (CSE)
(10%) was prepared by bubbling smoke from 1 cigarette into 10 ml of
culture medium at a rate of 1 cigarette per 2 minutes, as described
previously (39), with modifications (4, 15, 40, 41). The pH was adjusted
to 7.4 in the CSE, which was sterile filtered through a 0.45-mm filter
TABLE 1. PRIMER SEQUENCES USED IN CHROMATIN
IMMUNOPRECIPITATION ASSAY
Gene Primer Sequence
MIP-2 Sense 59-CAA CAG TGT ACT TAC GCA GAC G-39
Antisense 59-CTA GCT GCC TGC CTC ATT CTA C-39
IL-6 Sense 59-GAC ATG CTC AAG TGC TGA GTC AC-39
Antisense 59-AGA TTG CAC AAT GTG ACG TCG-39
Definition of abbreviation: MIP 5 macrophage inflammatory protein.
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(25-mm Acrodisc; Pall, Ann Arbor, MI). The CSE preparation was
standardized by monitoring the absorbance at 320 nm (optical density
of 0.74 6 0.05). The spectral variations observed between different
CSE preparations at 320-nm wavelength were found to be within
acceptable limits. CSE was freshly prepared for each experiment and
diluted with culture medium containing 1% FBS immediately before
use. Control medium was prepared by bubbling air through 10 ml of
culture medium supplemented with 1% FBS, adjusting pH to 7.4, and
sterile filtering as described for CSE preparation.
Treatments
MonoMac6, Ramos B, andWEHI-231 B cells were seeded at a density of
less than 13 106 cells/well (total final volume5 2ml), grown toz 80–90%
confluency in six-well plates containing RPMI 1640 medium with 10%
Figure 1. Cigarette smoke (CS) exposure increased the levels of RelB in
alveolar macrophages and alveolar/airway epithelial cells, but not in
CD191 B cells. Mice were exposed to CS for 3 days, and were killed at
24 hours after the last CS exposure. (A) Representative photographs
(4003) from immunostaining for serum (negative control), RelB, RelA,
and CD19 in lung tissues from air- and CS-exposed mice. Appearance
of dark brown color represents the presence of RelB and RelA, which
were increased in mouse lung cells in response to CS exposure. Arrows
indicate RelB- and RelA-positive macrophages, type II, and airway
epithelial cells. However, the expression of CD19 (B cells) was not
altered in lungs. Four slides of each sample of mouse lung tissue were
used for immunohistochemistry. Alv, alveoli; E, epithelial cells; M,
macrophages. (B) Immunostaining scores showing RelB and RelA per
cell type in alveolar and airway regions of the lung. The assessment of
immunostaining intensity was performed semiquantitatively in
a blinded fashion. Solid bars, intense staining; shaded bars, moderate/
weak staining; open bars, no staining. Results are means of five
experiments 6 SEM (n 5 5). *P , 0.05, **P , 0.01, and ***P ,
0.001, significantly different from respective air-exposed groups.
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FBS, washed in Ca21- and Mg21-free PBS, and then exposed to various
treatments in media containing 1% serum. The cells were treated with
CSE (0.5, 1.0, or 2.5%) for 1 hour at 378C with 7.5% CO2. To investigate
the involvement of proteolysis of RelB, Ramos B cells were pretreated
with 25 mM calpain inhibitor I (ALLN, product no. 208750; Calbiochem,
SanDiego, CA) for 20minutes. The pretreated cells were washed twice in
PBS and then treated with CSE (0.5 and 1.0%) for 1 hour at 378C with
7.5%CO2.Primary spleenBcells (73 107)were seeded in 100-mmculture
dishes containing RPMI 1640 with 1% FBS, 100 mg/ml penicillin, and 100
U/ml streptomycin, and treatedwithCSE (0.1 and 0.5%) for 1 and 4 hours
at 378C with 7.5% CO2. All treatments were performed in duplicate. At
the end of treatment, the cells were washed with cold, sterile Ca21- and
Mg21-free PBS and lysed in RIPA buffer as whole lysate (Western
blotting), and the lysates stored at2808C.
Transfection
The plasmids for wild-type IKK-a, dominant negative IKK-a and NIK
kinase mutant domain on lysine K429 and K430 (K429/A430) were
obtained as previously described (2, 42). Transient transfection was
performed with 1 mg of plasmids in the presence of Lipofectamine-2000
transfection reagent (product no. 11668–027; Invitrogen, Carlsbad, CA)
in MonoMac6, Ramos B, and WEHI-231 cells. Transfection efficiency
in the case of both the plasmids was greater than 80%. Following
transfection, MonoMac6, Ramos, and WEHI-231 B cells were treated
with CSE (0.5, 1.0, and/or 2.5%). Whole lysate was used in Western
blotting analysis.
Cytoplasmic and Nuclear Protein Extraction
A total of 100 mg of lung tissue was mechanically homogenized in
0.5 ml buffer A (10 mM HEPES, pH 7.8, 10 mM KCl, 2 mM MgCl2,
1 mM DTT, 0.1 M EDTA, 0.2 mM NaF, 0.2 mM Na orthovandate, 1%
[vol/vol] NP-40, 0.4 mM PMSF, and 1 mg/ml leupeptin) on ice. The
homogenate was centrifuged at 2,000 3 g in a benchtop eppendorf
centrifuge for 30 s at 48C to remove cellular debris. The supernatant
was then transferred to a 1.7 ml ice-cold microtube and further
centrifuged for 30 s at 13,0003 g at 48C. The supernatant was collected
as a cytoplasmic extract. The pellet was resuspended in 200 ml of buffer
C (50 mM HEPES, pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 M EDTA,
1 mM DTT, 10% [vol/vol] glycerol, 0.2 mM NaF, 0.2 mM
Na orthovandate, and 0.6 mM PMSF) and placed on the rotor in
the cold room for 30 minutes. After centrifugation at 13,000 3 g in a
micro-Eppendorf tube for 5 minutes, the supernatant was col-
lected as the nuclear extract and kept frozen at 2808C for Western
blotting.
Western Blotting
Lung tissue homogenate samples (cytoplasmic and nuclear proteins)
were separated on 7.5–12% SDS-PAGE. MonoMac6, Ramos, WEHI-
231, and primary mouse spleen B cells were harvested and lysed with
10% Igepal CA-630 lysis buffer supplemented with a protease inhibitor
cocktail (leupeptin, aprotinin, pepstatin, and PMSF). Equal amounts of
protein were subjected to electrophoresis on 7.5–12% PAGE gels,
electroblotted onto nitrocellulose membranes (Amersham Bioscience,
Piscataway, NJ), and then incubated overnight with primary antibodies
at 48C. The next day, membranes were washed and incubated for
1 hour at room temperature with the appropriate secondary antibody
linked to horseradish peroxidase (Dako, Santa Barbara, CA). Bound
complexes were detected with the use of the enhanced chemilumines-
cence method (Jackson Immunology Research, West Grove, PA).
Immunoprecipitation
A total of 100 mg of proteins in mouse lung tissue homogenate were
immunoprecipitated with 1 mg of specific antibodies and 20 ml of
protein A/G agarose beads (product no. SC-2003; Santa Cruz Bio-
technology) in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl,
0.25 mM EDTA, 5 mM NaF, 0.1% sodium deoxycholate, 1% Triton X-
100, in PBS) overnight at 48C. After immunoprecipitation, the precip-
itates were washed three times with 10 mM Tris, 1 mM EDTA, 150 mM
NaCl, 1 mg/ml BSA, 1% Triton X-100, and protease inhibitor in PBS
with spinning at 2,000 rpm for 1 minute at 48C. The precipitants were
resuspended in 50 ml of Laemmli sample buffer to a final concentration
of 13 sample buffer, and heated at 958C for 5 minutes. The collected
supernatants (immunoprecipitants) were run on 7.5% SDS-PAGE.
Figure 2. CS exposure in-
creased the level of RelB and
induced the interaction of
RelB with NF-kB–inducing ki-
nase (NIK) and p52 in mouse
lung. Mice were exposed to
CS for 3 days, and were killed
at 24 hours after the last CS
exposure. (A) The levels of
RelB and NIK were signifi-
cantly increased in both the
nucleus and cytoplasm of
cells in mouse lung tissue,
whereas the level of p52 was
increased only in the cyto-
plasm, but not in the nucleus,
in response to CS. b-actin was
used as a loading control
from the experiments de-
scribed previously (2). (B)
The level of RelB, and its in-
teraction with NIK and p52,
in lungs was increased in re-
sponse to CS (fold induction
versus control). Nuc, nucleus;
Cyt, cytoplasm. Data shown
are mean 6 SEM. *P , 0.05,
**P , 0.01, and ***P , 0.001,
significantly different from
respective air-exposed mice
(n 5 4/group). Open bars,
air; solid bars, CS.
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Chromatin Immunoprecipitation
A total of 100 mg of lung tissue was homogenized in 1 mg/ml BSA with
protease inhibitor cocktail in PBS, and cross-linked with 1% formal-
dehyde for 10 minutes, rinsed three times with PBS, and then 0.5 ml of
2.5 M glycine was added. After a brief centrifugation, cell pellets were
resuspended in SDS-lysis buffer (50 mM Tris-HCl, 1% SDS, 5 mM
EDTA, 5 mM Na-butyrate, protease inhibitors). Sonication of nuclear
pellets containing chromatin was performed four times for 30 seconds
and one time for 15 seconds, at a maximum speed, using Misonix-3000
Sonicator (Misonix Inc., Farmingdale, NY). Supernatants were col-
lected and diluted (1:10) with buffer (1% Triton X-100, 2 mM EDTA,
150 mM NaCl, 20 mM Tris-HCl, pH 8.0, 5 mM NaButyrate, protease
inhibitor), followed by preclearing the extract with 60 ml of protein A
agarose/salmon sperm DNA (no. 16-157; Upstate) for 3 hours at 48C
(43). Immunoprecipitation was performed overnight at 48C with 1 mg
of specific antibodies, as mentioned above. After immunoprecipitation,
40 ml of protein A agarose/salmon sperm DNA was added and
incubated for 2 hours and followed by brief centrifugation. Precipitates
were washed sequentially with Paro buffer I (0.1% SDS, 1% Triton X-
100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), Paro
buffer II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl,
pH 8.1, 500 mM NaCl), and Paro buffer III (0.25 M LiCl, 1% Igepal
CA-630, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1) for
5 minutes at 48C. Precipitates were then washed again with Tris buffer
twice for 5 minutes each. The antigen–antibody complexes were
extracted twice with 50 ml elution buffer (0.6 mg/ml proteinase K, 1%
SDS, 0.1 M NaHCO3). The eluted samples were heated at 658C
overnight to reverse formaldehyde crosslinking. The recovered DNA
was purified with a QIAquick PCR purification kit (product no., 28106;
Qiagen, Valencia, CA) (43). Samples of input DNA were also prepared
in the same way as described above. PCR amplification was performed
using a PTC-200 DNA engine (MJ Research, Waltham, MA) under the
following conditions: 948C for 180 seconds; 30–38 cycles at 948C for 45
seconds, 608C for 60 seconds, and 728C for 60 seconds; and final
elongation at 728C for 10 minutes. PCR for the input reaction was
performed using 100 ng of genomic DNA. Mouse primer sequences are
described in Table 1, and PCR products were analyzed on a 1.5–2.0%
agarose gel.
Protein Assay
Protein levels were measured with a BCA kit (Pierce, Rockford, IL).
Protein standards were obtained by diluting a stock solution of BSA.
Linear regression was used to determine the actual protein concentra-
tion of the samples.
Statistical Analysis
Results are shown as means 6 SEM. Statistical analysis of significance
was calculated by one-way ANOVA followed by Fisher’s protected
least significant difference post hoc test for multigroup comparisons
(StatView 5.0; SAS Institute, Cary, NC). Statistical significance is
indicated in the figure legends.
RESULTS
CS Exposure Increased the Levels of RelB and RelA/p65 in
Alveolar and Airway Epithelial Cells in Mouse Lung
We studied the expression and localization of RelB and RelA/
p65 in mouse lung sections by immunohistochemistry in mid-
sagittal sections in response to air or CS exposure. RelB- and
RelA/p65-positive cells with increased staining of RelB and
RelA/p65 were detected in macrophages, type II alveolar, and
airway epithelial cells in mouse lung tissue exposed to CS
(Figures 1A and 1B). However, we were unable to detect B cells
using the B-cell–specific surface marker CD191 in lung sections
of mice exposed to CS for acute (3-d) exposure (Figure 1A).
Likewise, the expression of CD45R/B220, another marker of B
cells, was also not detected in mouse lungs exposed to CS for
3 days. However, CD19- and CD45R/B220-positive cells were
increased in mouse lung after 8 weeks of CS exposure compared
Figure 3. CSexposure led to recruitment ofRelBonpromoters of IL-6and
MIP-2 genes inmouse lung.Micewere exposed toCS for 3 days and killed
at 24hours after the last CS exposure. (A) CS exposure caused recruitment
of RelB onMIP-2 and IL-6 promoters. The nuclear extracts were immuno-
precipitated with specific antibodies, and binding to the promoters of
proinflammatorymediatorgeneswasdetectedbyPCRprimers for IL-6and
MIP-2. Binding to the promoters was compared with PCR of the input
DNA from the experiments described previously (2). IgG was used as
a negative control. (B) The bands were measured by densitometry (fold
induction versus control). Data shown are mean 6 SEM. *P , 0.05, and
***P, 0.001, significantly different from respective air-exposedmice (n5
4/group).
Figure 4. CS exposure increased the levels of RelB-dependent proin-
flammatory mediators in mouse lung. The levels of RelB-dependent
proinflammatory cytokines were examined in bronchoalveolar lavage
fluid of mice exposed to CS for 3 days (24 h after the last exposure) by
Luminex-based multiplex assay. Data shown are mean 6 SEM (n 5
5–6/group). *P , 0.05, significant compared with air-exposed group.
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with air exposure (data not shown). These observations suggest
that CS exposure induced increased levels of RelB and RelA/
p65 and increased numbers of B cells in mouse lungs.
CS Exposure Increased the Levels of RelB and Its Interaction
with NIK and p52 in Mouse Lung
We determined the levels of RelB and its interactions with NIK
and p52 in lung tissue of mice exposed to CS for 3 days. The
levels of RelB and NIK were significantly increased in both the
nucleus and cytoplasm of cells in mouse lung tissue, whereas the
level of p52 was increased only in the cytoplasm, but not in the
nucleus in response to CS (Figures 2A and 2B). We next
determined the interaction of RelB with NIK and p52 in mouse
whole lung homogenates by immunoprecipitation with relevant
antibodies. CS increased the level of RelB interaction with both
NIK and p52 in mouse lungs (Figure 2B). These data showed
that CS exposure increased the levels of both RelB and NIK in
the nucleus, as well as the interactions of RelB with NIK and
p52 in mouse lung.
CS Exposure Caused Recruitment of RelB on Proinflammatory
Gene Promoters in Mouse Lung
It has been shown that increased levels of RelB are a pre-
requisite for the alternate pathway of NF-kB–dependent gene
transcription in response to proinflammatory stimuli (20, 21, 23,
27, 44, 45). Therefore, we hypothesized that CS exposure would
induce proinflammatory mediators by recruiting RelB on the
promoters of proinflammatory genes. To test this hypothesis,
chromatin immunoprecipitation (ChIP) assays were performed
using antibodies against RelB in lungs of mice exposed to CS.
As expected, the levels of RelB on the proinflammatory pro-
moter sites of macrophage inflammatory protein (MIP)-2 and
IL-6 were increased (Figures 3A and 3B). However, the regions
that were noncoding for IL-6 and MIP-2 showed no change in
gene expression, validating the specificity of the ChIP assays
(S.-R. Yang and coworkers, unpublished data). These results
demonstrate that RelB is recruited on the promoters of various
proinflammatory genes, thereby exerting its effect on proin-
flammatory gene expression in mouse lung.
CS Increased the Levels of NF-kB–Dependent
Proinflammatory Mediators in Mouse Lung
We next determined whether or not CS induced the levels of
RelB-dependent proinflammatory cytokines in mouse BAL
fluid measured by Luminex-based multiplex assay. The proin-
flammatory mediators, including CD40, CD40 ligand (which are
present on antigen-presenting cells, and are costimulatory
molecules for proliferation and enhanced survival of T cells),
eotaxin, and granulocyte chemotactic protein-2 (which are
Figure 5. CS extract (CSE) increased the levels of RelB and
p52, and IkB-kinase (IKK)-a activated RelB in human
monocyte/macrophages in response to CSE treatment.
(A) MonoMac6 cells were transfected with dominant
negative or wild-type IKK-a plasmids and treated with
CSE (0.5, 1.0, and 2.5%) for 1 hour. Protein levels of RelB
and p52 were then measured by Western blotting. CSE
increased the levels of RelB and p52 rapidly in non-
transfected cells, whereas the level of RelB was attenuated
in cells transfected with dominant negative IKK-a plas-
mids. Transfection of wild-type IKK-a increased the levels
of RelB and p52. b-actin was used as a loading control
from the experiments described previously (2). (B) The
bands were measured by densitometry (fold induction
versus control). Data shown are mean 6 SEM of four
experiments. *P , 0.05, **P , 0.01, and ***P , 0.001,
significantly different from respective controls; #P , 0.05,
##P , 0.01, and ###P , 0.001, significantly different from
respective nontransfected groups.
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thought to be regulated by alternative NF-kB pathways) were
significantly increased in BAL fluid in response to CS exposure
(Figure 4). Previously, we have shown that the levels of MIP-2
and IL-6 were increased in BAL fluid 3 days after CS exposure
(2). Taken together, these data suggest that CS induces the
alternative pathway of NF-kB–dependent proinflammatory
mediators in mouse lung.
CSE Increased the Levels of RelB, and IKK-a Is a Critical
Regulator of RelB in MonoMac6
Macrophages play an important role in abnormal inflammatory
responses observed in patients with COPD. Recently, we have
shown that CS induces proinflammatory mediators by an NF-
kB–dependent mechanism in macrophages (2, 4). We therefore
determined whether RelB was also activated in response to
CSE in MonoMac6 cells, leading to RelB-dependent proin-
flammatory cytokine release. Similar to the activation of RelA/
p65 (2), we found that RelB was activated in response to CSE
treatment associated with increased levels of its partner, p52
(Figures 5A and 5B). These data suggested that CS activates
both the classical and the alternative NF-kB pathways in
macrophages, leading to proinflammatory mediator release.
It was recently shown that NIK activates the IKK-a homo-
dimer in the IKK-s complex, which, in turn, results in activation
of alternative NF-kB pathway, characterized by nuclear trans-
location of RelB (22, 44). Therefore, we determined whether
NIK and IKK-a were involved in regulation of RelB in response
to CSE in MonoMac6 cells. Macrophages were transfected with
a dominant negative IKK-a or a double mutant of NIK (K429/
A430), and treated with CSE (0.5, 1.0, and 2.5%) for 1 hour. The
levels of RelB and p52 were increased in response to CSE in
nontransfected cells, whereas the level of RelB was attenuated in
both dominant negative IKK-a–transfected and double mutant
of NIK (K429/A430, S.-R. Yang and coworkers, unpublished
data)-transfected MonoMac6 cells. Transfection of wild-type
IKK-a increased the levels of RelB and p52, suggesting that
IKK-a and NIK are required for CS-mediated activation of
alternative NF-kB pathway in macrophages (Figure 5A and 5B).
CSE Rapidly Degraded RelB in Ramos (Human), WEHI-231
(Mouse), and Spleen B Cells (Mouse), and the Loss of IKK-a
Partially Restored RelB
Immune–inflammatory lymphoid cells appear to be important
in the pathogenesis of COPD (12, 13), and RelB controls the
alternate NF-kB pathways in these cells by forming a transcrip-
tionally inactive complex with RelA/p65 (20, 21, 24, 25, 46).
Hence, we determined the levels of RelB in response to CSE in
B cells (human Ramos B-cells, mouse WEHI-231 B cells, and
primary spleen B cells). In contrast to RelA/p65 activation in
macrophages, we found that RelB was rapidly degraded in
response to CSE treatments in B cells (Figures 6–8). Further-
Figure 6. CSE rapidly de-
graded RelB, and loss of IKK-a
partially restored RelB in human
B cells. Ramos B cells were
transfected with a dominant
negative IKK-a plasmid and
treated with CSE (0.5 and
1.0%) for 1 hour. Protein levels
of RelB, IKK-a, NIK, and RelA/
p65 were measured by Western
blotting. The level of RelB was
significantly decreased in re-
sponse to CSE, whereas the
levels of IKK-a, NIK, and RelA/
p65 were significantly in-
creased. However, the level of
RelB was partially restored in
cells transfected with dominant
negative IKK-a plasmid. Fur-
thermore, the level of RelB
was partially attenuated,
whereas the levels of NIK and
RelA/p65 were normalized in
cells transfected with wild-type
IKK-a plasmid. (B) The bands
were measured by densitome-
try (fold induction versus con-
trol). Data shown are mean 6
SEM of four experiments. *P ,
0.05, **P , 0.01, and ***P ,
0.001, significantly different
from respective controls; #P ,




Yang, Yao, Rajendrasozhan, et al.: Differential Role of RelB in Inflammation 153
more, the levels of p100 and p52 were also decreased in primary
splenic B cells in response to CSE treatment, suggesting that CS
exposure down-regulates the alternative NF-kB pathway in B
cells (Figure 8).
We next determined whether CS-mediated degradation of
RelB was associated with down-modulation of its signaling by
NIK and IKK-a in B cells. Surprisingly, we found that CSE
caused activation of both NIK and IKK-a, and that transient
transfection with a dominant-negative IKK-a partially restored
CSE-mediated loss of RelB, whereas transfection of double
mutant of NIK (K429/A430) completely restored CSE-medi-
ated loss of RelB in B cells (Figures 6 and 7). However, the
levels of NIK and RelA/p65 were not changed in response to
CSE in cells transfected with a dominant negative IKK-a
plasmid compared with nontransfected cells. Furthermore, the
levels of NIK and RelA/p65 were returned to basal levels in
cells transfected with wild-type IKK-a. These data suggest that
IKK-a activation may not be critical for CSE-mediated loss of
RelB in B cells.
The Proteasome Inhibitor, Acetyl-L-Leucyl-L-Leucyl-
Norleucinal, Prevented the Degradation of RelB in Response
to CSE in B Cells
We hypothesized that CSE-mediated degradation of RelB in B
cells is associated with proteasomal degradation. To determine
the involvement of proteolysis of RelB, Ramos B cells were
pretreated with a proteasome inhibitor (ALLN) and exposed to
CSE and levels of RelB were determined. ALLN treatment
prevented the degradation of RelB (Figures 9A and 9B).
However, ALLN did not affect the levels of RelA/p65 (S.-R.
Yang and coworkers, unpublished data). These data indicate
that, in B cells, RelB is regulated by a proteasome-dependent
degradation.
DISCUSSION
The absolute volume of infiltrated inflammatory immune cells
in lymphoid follicles in the small airways is associated with the
progression of COPD (12). This suggests that recruitment of
lymphoid cells (T and B lymphocytes) in the lung may occur in
response to chronic CS exposure. This concept is supported by
a recent study showing that B cells are increased in the lungs
of patients with emphysema and in mouse lungs chronically
exposed to CS (13). These observations were corroborated by
our findings showing increased CD19- and CD45R/B220-posi-
tive cells (B cells) in mouse lungs exposed to CS for 8 weeks.
However, 3 days of CS exposure did not show increases in the
number of B cells. These studies suggest that chronic CS
exposure recruits B cells into the lung. However, the functional
role of B cells in the pathogenesis of COPD is not known. Here,
we studied the alternative NF-kB signaling events that control
the activation of RelB in B lymphocytes and macrophages
in vitro and in mouse lung in vivo in response to CS exposure.
We show that CS differentially regulates the level of RelB in
lung structural cells, macrophages, and B lymphocytes, suggest-
ing opposing effects of CS on RelB activation in a cell-specific
manner. It is known that RelB activation is tissue- and cell-
Figure 7. CSE rapidly de-
graded RelB, and loss of IKK-a
and NIK restored RelB in
mouse B cells. Mouse imma-
ture WEHI-231 B cells were
transfected with dominant
negative IKK-a and double
mutant of NIK (K429/A430)
plasmids and treated with
CSE (0.5 and 1.0%) for 1 hour.
Protein levels of NIK, IKK-a,
RelB, and RelA/p65 were mea-
sured by Western blotting. CSE
reduced the levels of RelB, and
increased the levels of NIK and
IKK-a in nontransfected cells,
whereas the CSE-mediated re-
duction in level of RelB was
partially attenuated when the
cells were transfected with
dominant negative IKK-a and
completely restored in double
mutant of NIK (K429/A430)
plasmid transfected cells. The
level of RelA/p65 was in-
creased in nontransfected cells
in response to CSE. However,
the levels of RelA/p65 and NIK
were attenuated in cells trans-
fected with dominant negative
IKK-a and double mutant of
NIK (K429/A430) plasmids. b-
actin was used as a loading
control. (B) The bands were
measured by densitometry
(fold induction versus control).
Data shown are mean 6 SEM of four experiments. *P , 0.05, **P , 0.01, and ***P , 0.001, significantly different from respective controls; #P ,
0.05, ##P , 0.01, and ###P , 0.001 significantly different from respective nontransfected groups.
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specific, especially in lymphoid organs and lymphoid cells, such
as B and T cells and fibroblasts (20–22, 24, 25). In these cells,
RelB acts as an inhibitor of transcription of proinflammatory
genes, whereas it functions as proinflammatory in nonlymphoid
cells (47). Here, we have expanded on these findings to study
the expression of RelB in airway and alveolar epithelial cells
and alveolar macrophages in response to CS. Immunohisto-
chemical staining of mouse lung tissue sections demonstrated
the localization of RelB in airway and alveolar epithelial cells,
as well as in alveolar macrophages in response to CS exposure.
Similarly, our data show increased levels of RelB in the lungs of
mice exposed to CS. These new data support recent studies
showing that TNF-a stimulation resulted in increased RelB
levels in both the cytoplasm and the nucleus of mouse intestinal
cells and macrophages, as well as in lymphoid cells (48, 49).
Furthermore, TNF-a, IL-1b, and CD40L were induced in
response to CS exposure in mouse lungs (2). Hence, CSE-
induced TNF-a, IL-1b, and CD40L release may activate RelB
pathways in mouse lung.
RelB-containing complexes can act as both activators and
repressors of NF-kB–dependent gene transcription (25). For
instance, the recruitment of RelB to the IL-12p40 promoter
correlates with transcriptional down-regulation, whereas RelB
up-regulates gene expression of certain proinflammatory media-
tors, such asCD40,CD40 ligand, eotaxin, granulocyte chemotactic
protein-2, ELC/CCL19 (EBl1 ligand chemokine), macrophage-
derived chemokine, RANTES, MIP-1a, MIP-1b, MIP-2, IP-10,
MCP-1, KC/CINC (IL-8), IL-13, IL-1b, TNF-a, and IL-4 genes
(13, 21, 50, 51). We have previously shown that CSE causes
activation of certain proinflammatory cytokines in macrophages
(MonoMac6 cells) and airway epithelial cells (2, 4, 41). Here, we
show that RelB was recruited onto the promoters of certain
proinflammatory cytokine genes in mouse lung tissues by CS,
suggesting that these cytokineswere up-regulated due toRelBand
RelA/p65 activation in macrophages and epithelial cells. We
observed that RelBwas also activated inMonoMac6 cells exposed
toCSE.Thiswas associatedwith increasedactivationof p52,which
forms active RelB:p52 complex. CS increased the level of RelB
associated with its interaction with p52 and NIK in mouse lung,
suggesting that this complex was active for gene transcription,
which was confirmed by the ChIP assay.
Themain inhibitor ofRelB is p100, and generation of p52/RelB
results from proteolytic cleavage of a unique pool of p100/RelB
(44). The p100 functions as IkBa, inhibiting the RelB-mediated
gene transcription. Furthermore, p100 is directly phosphorylated
byNIK-IKK-a, and causes its processing into p52 in the cytoplasm
(27, 44). RelB:p100 complex is inhibitory, whereas RelB or
RelB:p52 can induce certain proinflammatory genes. Our obser-
vation of increased levels of p52 in the cytoplasm implies that p100
is cleaved by IKK-a signaling in mouse lungs in response to CS.
However, the level of p52 in the nucleus was not detected,
suggesting that RelB directly binds on the promoters of certain
proinflammatory genes, as shown by the ChIP assay.
It is interesting to note that RelB is differentially regulated by
CS in mouse lung tissue, macrophages, and B lymphocytes.
Surprisingly, RelB was rapidly degraded in B cells in response to
CSE exposure. A question can be posed regarding the signaling
mechanism whereby RelB is differentially regulated in different
cells, and what the significance is for these opposing effects.
Previously, it has been shown thatNIKand IKK-a act as activators
of RelB:p52–NF-kB–controlled gene transcription and lymphoid
cell proliferation (52, 53). Furthermore, it is known that IKK-a
regulates the late differentiation of B cells by intrinsic NIK-IKK-a
signaling (22).Ournewdata show thatRelB is associatedwithNIK
in CS-exposed mouse lung tissue. We further determined whether
or not NIK and IKK-a were involved in the regulation of RelB in
Figure 8. CSE down-regulates the alter-
native NF-kB pathway in mouse spleen B
cells. Primary mouse spleen B cells were
isolated using a B cell isolation kit and
treated with CSE (0.1 and 0.5%) for 1 or
4 hours. Protein levels of RelB, p100, and
p52 were measured by Western blotting.
(A) CSE (0.1 and 0.5%) treatment signif-
icantly reduced the levels of RelB, p100,
and p52 in primary spleen B cells at both
1- and 4-hour time points. b-actin was
used as a loading control. (B) The bands
were measured by densitometry (fold
induction versus control). Data shown
are mean 6 SEM of three experiments.
**P , 0.01 and ***P , 0.001, signifi-
cantly different from respective controls.
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response to CSE in MonoMac6 cells. CSE-mediated increased
levels of RelB were reduced when the cells were transfected with
a dominant negative IKK-a or a double mutant of NIK (K429/
A430). Transfection of wild-type IKK-a increased RelB levels,
suggesting that NIK–IKK-a signaling was required for CS-medi-
ated activation of RelB in macrophages. We then used a similar
approach of gain and loss of NIK and IKK-a, and determined
whether or not CS-mediated degradation of RelB was associated
withdown-modulationof its signalingbyNIKandIKK-a inBcells.
Surprisingly,we found thatCSEcausedactivationofbothNIKand
IKK-a, and transient transfectionwith a dominant negative IKK-a
or a double mutant of NIK (K429/A430) partially restored CSE-
mediated loss of RelB in B cells. These data suggest that, apart
fromNIK-IKK-a activation, there is another signalingmechanism
for CSE-mediated regulation of RelB in B cells.
In contrast to lung cells and macrophages, the level of RelB
was decreased in B cells, suggesting that its degradation was
regulated by a proteasome-dependent mechanism. It is known
that RelB is degraded by rapid phosphorylation at amino acids
Thr84 and Ser52, followed by cleaving N-terminal amino acids
and complete degradation in the proteasome (24). Our data
show that the proteasome inhibitor, ALLN, prevented the
degradation of RelB in response to CSE in B cells. These
results agree with the concept that RelB is an essential regulator
required for suppression of NF-kB function and modulation of
chemokine expression in activated B and T cells and fibroblasts
(21). This contention is supported by the observations that the
disruption of the RelB locus results in impaired cellular
immunity and severe pathology associated with dysfunction of
the hematopoietic system and inflammatory response in lungs of
RelB2/2 mice (54). Furthermore, Xia and coworkers (21) have
also demonstrated that RelB is an important regulator of
chemokine expression in mouse fibroblast and lymphoid cells,
thereby playing a key role in the resolution of acute inflamma-
tion by inhibiting RelA/p65.
RelB is known to dampen RelA/p65 activity (20, 25). RelB
forms transcriptonally inactive complexes with RelA/p65, so
that RelA/p65 is unable to bind to kB sites in fibroblasts (25).
Moreover, serine-276 domain of RelA/p65 seems to be a critical
phosphorylation site for TNF-a–induced RelA/RelB complex
formation. It is possible that down-regulated alternative NF-kB
pathway (RelB degradation and decreased levels of p100 and
p52) would lead to RelA/p65 activation, as seen in lymphoid
cells in response to CSE. Overexpression of RelB suppresses
LPS-induced NF-kB activity and proinflammatory mediator
release in fibroblasts (20). It is also known that RelB modulate
IkB-a stability and suppresses the production of certain cytokines
in fibroblasts (20). RelB exerts its transcriptional suppressor
function through the stabilization of IkB-a protein. Activation of
RelA/p65, along with recruitment of IKK-a on proinflammatory
gene promoters, would lead to acetylation of histone proteins in
response to CS (2). Hence, our data imply that RelB degradation
would lead to chromatin remodeling and modification of RelA/
p65, which would influence excessive expression of proinflamma-
tory cytokines in response to CS. RelA/p65 is translocated into the
nucleus, leading to NF-kB activation in response to stimuli.
However, the level of RelA/p65 was increased in whole lysates
of B cells in response to CS exposure, which is consistent with our
previous studies (4, 14). The mechanism underlying this finding is
not known, but it may be associated with a positive autocrine
regulation by RelA/p65 in response to CS. Although RelB was
differentially regulated in mouse lungs, macrophages, and B cells
by CS, the direct role of RelB in CS-mediated lung inflammatory
response is not clear. The use of RelB-deficient mice and the cells
deficient in RelB may elucidate the role of RelB in CS-mediated
lung inflammatory–immune and injurious responses.
The degradation of RelB in response to CSE in B cells will
have consequences on altering acquired immunity, as tobacco
smoke–reactive agents can react with components of extracel-
lular matrix proteins to form new, highly immunogenic protein
adducts, such as aldehyde-modified proteins. Immune complex
formation may occur, eliciting an inflammatory response,
altering antibody production (perhaps by inducing autoantibody
production), and subsequently harbor bacteria and viruses or
vice-versa in lymphoid follicles in lungs of patients with COPD.
In this way, B cells may start producing autoantibodies in
response to CS, which appears to occur in patients with COPD
(55, 56). The proinflammatory and antiinflammatory (RelA
versus RelB) pathways are differentially modified in B cells in
response to CS, and this alteration may be key in signaling
autoantibody production in COPD.
In summary, CS regulates RelB differentially in a cell-
specific manner, and NIK-IKK-a is involved in RelB regulation.
In structural cells of the lungs and macrophages, RelB was
increased due to the activation of NIK-IKK-a, and RelB was
recruited onto proinflammatory gene promoters. In contrast,
RelB was degraded rapidly by proteolysis in B lymphocytes,
independent of NIK-IKK-a activation in response to CSE. Our
findings not only provide novel concepts of cell type–specific
differential regulation of RelB in response to CS, but also a new
understanding that the alternative NF-kB pathway might be
considered as a critical target for COPD therapies, particularly
in lymphoid cells.
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Figure 9. CSE decreased the level of RelB via proteasome-mediated
degradation in B cells. (A) CSE dose-dependently decreased the levels
of RelB in B cells, and the proteasome inhibitor, ALLN, prevented the
degradation of RelB by a proteasome-dependent mechanism. The cells
were pretreated with the proteasome inhibitor, ALLN (25 mM), for
20 minutes before exposure to CSE (0.5 and 1.0%) for 1 hour. The level
of RelB in whole cell lysates was then measured by immunoblotting. (B)
The bands were measured by densitometry (fold induction versus
control). Data shown are mean 6 SEM of four experiments. ***P ,
0.001, significantly different from respective controls.
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